Besides identifying increased IFI16 gene expression levels in SLE, increased levels have also been reported to be closely related to disease activity (54), pointing to IFI16 as a candidate blood biomarker during an ongoing ENL episode. This evidence concerns the gene IFI16 and systemic lupus erythematosus.